Camex

Who are in the management team of Camex?

As of March 2023, the management team of Camex includes Chandraprakash Chopra (Managing Director), Jitendra Chopra (Whole-time Director), and several Non-Executive & Independent Directors, along with Kruti Shah (Company Secretary) and Rahul Chandraprakash Chopra (Director). This team combines executive leadership with independent oversight.

As of March 2023, the management team of Camex includes the following individuals:<BR><BR>1. Chandraprakash Chopra - Managing Director<BR>2. Jitendra Chopra - Whole-time Director<BR>3. Sunil Tarachand Kothari - Non-Executive & Independent Director<BR>4. Indra Balveermal Singhvi - Non-Executive & Independent Director<BR>5. Kruti Shah - Company Secretary & Compliance Officer<BR>6. Arpit Shah - Non-Executive & Independent Director<BR>7. Rahul Chandraprakash Chopra - Director<BR><BR>This team brings a mix of executive and independent oversight to the company's operations.

Has Camex declared dividend?

Camex Ltd has declared a 5% dividend, amounting to $0.5 per share, with an ex-date of September 8, 2014. However, the dividend yield is 0%, indicating it has not contributed to returns in recent periods, despite significant gains over the longer term.

Camex Ltd has declared a 5% dividend.<BR><BR>Dividend Details:<BR>- Percentage announced: 5%<BR>- Amount per share: 0.5<BR>- Ex-date: 08 Sep 14<BR><BR>Dividend Yield: 0%<BR><BR>Total Returns by Period:<BR>In the 6-month period, the price return was -31.81%, the dividend return was 0%, resulting in a total return of -31.81%.<BR><BR>For the 1-year period, the price return was -13.68%, the dividend return was 0%, leading to a total return of -13.68%.<BR><BR>Over the 2-year period, the price return was 47.96%, the dividend return was 0%, which resulted in a total return of 47.96%.<BR><BR>In the 3-year period, the price return was 48.62%, the dividend return was 0%, culminating in a total return of 48.62%.<BR><BR>For the 4-year period, the price return was 29.24%, the dividend return was 0%, resulting in a total return of 29.24%.<BR><BR>In the 5-year period, the price return was 219.26%, the dividend return was 0%, leading to a total return of 219.26%.<BR><BR>Overall, while Camex Ltd has declared a dividend, the dividend yield remains at 0%, indicating that the dividend has not contributed to returns in recent periods. The total returns show variability, with significant gains over longer periods, particularly in the 5-year span.

Who are the peers of the Camex?

Camex's peers include Tata Chemicals, Chemplast Sanmar, India Glycols, GHCL, and others. Management risk varies from excellent at GHCL to below average at Camex, with India Glycols showing the highest 1-year return at 150.38%, while Camex has a return of -19.98%.

Peers: The peers of Camex are Tata Chemicals, Chemplast Sanmar, India Glycols, GHCL, Fischer Medical, Genus Prime, Haryana Leather, Ritesh Intl., Deco-Mica, and TCM.<BR><BR>Quality Snapshot: Excellent management risk is observed at GHCL and Chemplast Sanmar, while Average management risk is found at Tata Chemicals, India Glycols, Haryana Leather, and Ritesh Intl., and the rest. Below Average management risk is noted at Fischer Medical, Camex, and TCM, while Genus Prime does not qualify. Growth is classified as Good at Ritesh Intl., Average at Fischer Medical, and Below Average at Tata Chemicals, Chemplast Sanmar, India Glycols, GHCL, Camex, Haryana Leather, Deco-Mica, and TCM, with Genus Prime not qualifying. Capital Structure is Excellent at GHCL, Good at Fischer Medical and Haryana Leather, Average at Tata Chemicals and Ritesh Intl., and Below Average at Chemplast Sanmar, India Glycols, Camex, Deco-Mica, and TCM.<BR><BR>Return Snapshot: India Glycols has the highest 1-year return at 150.38%, while Camex has a 1-year return of -19.98%, which is significantly lower than India Glycols. Additionally, the six-month return is negative for Tata Chemicals, Chemplast Sanmar, GHCL, and TCM.

What is the technical trend for Camex?

As of April 22, 2025, Camex's technical trend is mildly bearish, influenced by daily moving averages and mixed signals from MACD and Bollinger Bands, with a mildly bullish stance on the weekly chart and a mildly bearish outlook on the monthly chart.

As of 22 April 2025, the technical trend for Camex has changed from bearish to mildly bearish. The weekly MACD indicates a mildly bullish stance, while the monthly MACD is mildly bearish, suggesting mixed signals. The Bollinger Bands show a bullish outlook on the weekly chart but are mildly bearish on the monthly chart. Moving averages on the daily timeframe are mildly bearish, which aligns with the overall trend. The KST is mildly bullish on the weekly but mildly bearish on the monthly, and Dow Theory supports a mildly bullish view on both timeframes. Overall, the current stance is mildly bearish, driven primarily by the daily moving averages and the mixed signals from MACD and Bollinger Bands.

What does Camex do?

Camex Ltd is a micro-cap company in the commodity chemicals sector, specializing in direct dyes for cotton, paper, and leather. As of March 2025, it reported net sales of 372 Cr and a net profit of 2 Cr, with a market cap of INR 42 Cr.

Overview: <BR>Camex Ltd is a micro-cap company in the commodity chemicals industry, specializing in the manufacture of direct dyes used for dyeing cotton, paper, and leather.<BR><BR>History: <BR>Camex Ltd was incorporated in 1989 by Mr. C.P. Chopra and has experienced significant growth with the support of his brother, Mr. Devendra Chopra. The latest quarterly results reported net sales and profit for March 2025.<BR><BR>Financial Snapshot: <BR>Most recent Net Sales: 372 Cr (Quarterly Results - Mar 2025) <BR>Most recent Net Profit: 2 Cr (Quarterly Results - Mar 2025) <BR>Market-cap value: INR 42 Cr (Micro Cap)<BR><BR>Key Metrics: <BR>P/E: 21.00 <BR>Industry P/E: 35 <BR>Dividend Yield: 0.00% <BR>Debt Equity: -0.07 <BR>Return on Equity: 4.58% <BR>Price to Book: 0.98 <BR><BR>Contact Details: <BR>Address: Camex House Navrangpura, Stadium 2nd Flr Commerce Road Ahmedabad Gujarat : 380009 <BR>Tel: 91-79-26462123/26462261 <BR>Email: cs@camexltd.com <BR>Website: http://www.camexltd.com

Who are the top shareholders of the Camex?

The top shareholders of Camex include Chandraprakash Bhanwarlal Chopra with 18.78%, Rajesh Nahata with 9.74%, and individual investors holding a combined 37.67%. There are no institutional holdings or pledged promoter shares.

The top shareholders of Camex include Chandraprakash Bhanwarlal Chopra, who holds the highest promoter stake at 18.78%. The highest public shareholder is Rajesh Nahata, with a holding of 9.74%. Additionally, individual investors collectively hold 37.67% of the company's shares. There are no institutional holdings or pledged promoter shares reported.

How big is Camex?

As of 24th July, Camex Ltd has a market capitalization of 42.00 Cr and reported Net Sales of 146.84 Cr with a Net Profit loss of 0.04 Cr over the latest four quarters. As of March 2022, Shareholder's Funds were 37.17 Cr and Total Assets were 65.03 Cr.

As of 24th July, Camex Ltd has a market capitalization of 42.00 Cr, categorizing it as a Micro Cap company.<BR><BR>In the latest four quarters, Camex reported Net Sales of 146.84 Cr. However, the company experienced a loss of 0.04 Cr in Net Profit during the same period.<BR><BR>The latest annual period for the balance sheet is March 2022, where Shareholder's Funds amounted to 37.17 Cr and Total Assets were valued at 65.03 Cr.

When is the next results date for Camex?

Camex will declare its results on 12 August 2025.

Camex will declare its results on 12 August 2025.

How has been the historical performance of Camex?

Camex's historical performance shows a decline in net sales from 179.25 Cr in Mar'22 to 146.84 Cr in Mar'23, resulting in a loss with a consolidated net profit of -0.01 Cr compared to 3.18 Cr the previous year. The company faced significant challenges, marked by decreasing profitability and operating income.

Answer:<BR>The historical performance of Camex shows a fluctuating trend in net sales and profitability over the years, culminating in a loss in the most recent fiscal year.<BR><BR>Breakdown:<BR>Camex's net sales decreased from 179.25 Cr in Mar'22 to 146.84 Cr in Mar'23, reflecting a downward trend after a peak of 150.17 Cr in Mar'21. Total operating income followed a similar pattern, dropping to 146.84 Cr in Mar'23 from 179.25 Cr in Mar'22. The company's total expenditure also decreased from 176.78 Cr in Mar'22 to 146.53 Cr in Mar'23, with raw material costs and purchase of finished goods contributing significantly to the overall expenses. Operating profit, excluding other income, fell sharply to 0.31 Cr in Mar'23 from 2.47 Cr in Mar'22, leading to a profit before tax of -0.07 Cr in Mar'23, down from 4.07 Cr in the previous year. Consequently, the profit after tax also turned negative, resulting in a consolidated net profit of -0.01 Cr in Mar'23, compared to 3.18 Cr in Mar'22. The company's earnings per share reflected this downturn, dropping to -0.01 in Mar'23 from 3.11 in Mar'22. Additionally, total assets decreased from 65.03 Cr in Mar'22 to 65.03 Cr in Mar'23, while total liabilities also saw a decline from 65.03 Cr to 65.03 Cr. Overall, Camex's financial performance indicates significant challenges in the latest fiscal year, marked by declining sales and profitability.

Is Camex overvalued or undervalued?

As of November 13, 2025, Camex is considered very expensive and overvalued due to its high PE ratio of 69.61, low ROE of 1.18%, and poor stock performance, especially compared to peers like Lloyds Enterprises and PTC India.

As of 13 November 2025, Camex's valuation grade has moved from attractive to very expensive, indicating a significant shift in its market perception. The company is currently overvalued, as evidenced by its high PE ratio of 69.61, an EV to EBITDA ratio of 11.27, and a low ROE of 1.18%. These metrics suggest that the market is pricing in excessive growth expectations that may not be sustainable.<BR><BR>In comparison to its peers, Camex stands out with a notably high PE ratio, especially when compared to Lloyds Enterprises at 29.63 and PTC India at 7.67, both of which are more reasonably valued. The disparity in valuation is further highlighted by Camex's PEG ratio of 0.00, indicating no growth expectations factored into its price, contrasting sharply with the higher ratios of its peers. Additionally, Camex's recent stock performance has been poor, with a year-to-date return of -42.48%, significantly underperforming the Sensex's 8.11% return. This underperformance reinforces the notion that Camex is overvalued in the current market environment.

Are Camex Ltd latest results good or bad?

Camex Ltd's latest results show mixed signals, with a 29.81% quarter-on-quarter sales growth but a concerning 30.92% year-on-year decline in stock performance and low profitability metrics. Overall, the financial health raises red flags, suggesting the results are more negative than positive.

Camex Ltd's latest results present a mixed picture, but overall, they indicate significant challenges. In Q3 FY26, the company reported net sales of ₹36.62 crores, reflecting a strong quarter-on-quarter growth of 29.81%. However, this improvement is overshadowed by a year-on-year decline of 30.92% in stock performance, which is considerably worse than both the Sensex and its sector.<BR><BR>While the sequential sales growth is a positive sign, the company's profitability metrics remain concerning. The average Return on Capital Employed (ROCE) is only 6.06%, and the Return on Equity (ROE) is a mere 4.87%, both of which are significantly below industry standards. Additionally, the operating margin stands at just 1.84%, indicating ongoing struggles to generate meaningful profits.<BR><BR>The stock's high P/E ratio of 68 times raises questions about its valuation, especially given the weak fundamentals. Furthermore, the company has shown inconsistent revenue generation and has been unable to maintain positive operating margins consistently.<BR><BR>In summary, while there are some signs of recovery in sales, the broader financial health of Camex Ltd raises red flags, suggesting that the results can be viewed as more negative than positive overall. Investors should approach with caution, considering the structural challenges the company faces.

Should I buy, sell or hold Camex Ltd?

Why is Camex Ltd falling/rising?

As of 18-Apr, Camex Ltd's stock price is rising to 31.38, up 1.65%. Despite this increase, the stock has declined 7.38% year-to-date and 21.45% over the past year, with declining investor participation indicated by a 51.2% drop in delivery volume.

As of 18-Apr, Camex Ltd's stock price is rising, currently at 31.38, with a change of 0.51 (1.65%) upward. This increase can be attributed to its recent performance, as the stock has outperformed its sector by 0.62% today. Additionally, over the past week, Camex Ltd has shown a positive return of 4.25%, which is significantly higher than the Sensex's return of 1.22% for the same period. <BR><BR>However, it is important to note that despite the current rise, the stock has experienced a decline of 7.38% year-to-date and a substantial drop of 21.45% over the past year. The stock's performance is also characterized by higher prices compared to its 5-day, 20-day, and 50-day moving averages, although it remains below the 100-day and 200-day moving averages. <BR><BR>Investor participation appears to be declining, as indicated by a significant drop in delivery volume by 51.2% against the 5-day average. Despite this, the stock remains liquid enough for trading. Overall, while Camex Ltd is currently experiencing a rise in its stock price, the broader context shows mixed performance trends that investors should consider.

Which are the latest news on Camex?